히스패닉 암 생존자의 수면 품질에 대한 라틴 춤의 영향
Moviendo Las Caderas : 히스패닉 암 생존자의 수면 품질에 대한 라틴 춤의 영향
The primary objective is to assess the feasibility, acceptability and explore the impact of a culturally appropriate Latin Dance intervention vs. Usual Care on sleep quality for Hispanic cancer survivors.
Secondary objectives are to examine the preliminary efficacy of a culturally appropriate Latin Dance intervention on secondary cancer- and treatment-related side effects (e.g., Quality of Life, distress, insomnia, fatigue).
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
In this feasibility Randomized Control Trial (RCT) study, the investigators will assess the feasibility, acceptability, and explore the impact of a Latin dance intervention vs usual care on sleep quality among Hispanic survivors.
Study Aims:
Aim 1: Develop a culturally appropriate Latin dance intervention for Hispanic cancer survivors using a bidirectional community engagement approach. Using iterative qualitative feedback from Hispanic cancer survivors, the investigators will develop a Latin dance intervention for Hispanic cancer survivors.
Aim 2: Assess the feasibility and acceptability of a culturally appropriate Latin Dance intervention for Hispanic cancer survivors.
Aim 3: Provide preliminary evidence of the efficacy potential of a culturally appropriate Latin Dance intervention vs. usual care on subjective and objective sleep quality for Hispanic survivors.
연구 유형
연구 유형
등록 (추정된)
등록
단계
단계
- 해당 없음
연락처 및 위치
연구 연락처
연구 연락처
- 이름: Evelyn Arana, DrPH
- 전화번호: 908-642-0861
- 이메일: earana@CINJ.Rutgers.edu
연구 연락처 백업
- 이름: Arlette Chavez, MD
- 전화번호: 732-715-4923
- 이메일: ac2758@CINJ.Rutgers.edu
연구 장소
-
-
New Jersey
-
New Brunswick, New Jersey, 미국, 08901
- 모병
- Rutgers Cancer Institute
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Be 18 years of age or older
- Self-identify as Hispanic and/or Latino(a)
- Have a confirmed diagnosis of a solid tumor or hematologic malignancy
- Must have completed primary cancer treatment 3+ months prior to enrollment (e.g., chemotherapy, surgery, and/or radiation therapy but may be on hormonal therapy and/or immunotherapy or other long-term therapies)
- Have sleep disturbance (indicated by a response of 3 or more on the MD Anderson Symptom Inventory sleep question by using an 11-point scale anchored by 0 [no sleep disturbance] and 10 [worst possible sleep disturbance]
- Be able to read and understand English and/or Spanish
- Physically Inactive (<150 minutes of vigorous exercise/week within the past 3 months)
Exclusion Criteria:
- Current regular Latin dancing practice within the past year (2-3 times a week over a period of two months that is not interrupted).
- Inability to speak and read English or Spanish proficiently
- Inability to understand informed consent
- Medical conditions that can cause sleep impairment: sleep apnea, restless leg syndrome, shift work
- Regular use of a walker or wheelchair
- Healing or unhealed fractures
- Heart failure
- Life expectancy <12 months
- Unwilling to be randomized to study arms and/or commit to 8 weeks of classes and a follow-up assessment
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 하나의
팔의 수
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
간섭 없음: Usual care arm
Participants in the usual care arm will receive care as usual and will not participate in the Latin Dancing program. |
|
|
실험적: Intervention arm
Participants in this arm will participate in the virtual Latin Dance group program that meets for 8 weeks, 2x each week, for 75 minute sessions. |
Latin Dance intervention
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Feasibility of the Intervention
기간: 8 weeks
|
Feasibility in this study will include recruitment, adherence, and retention rates. |
8 weeks
|
|
Treatment Perception Questionnaire (Acceptability of Intervention)
기간: Post-intervention (at approximately 8 weeks)
|
Acceptability is defined as at least 80% of participants in the Latin Dance group agreeing or strongly agreeing that the intervention was acceptable via the Treatment Perceptions Questionnaire (TPQ). The TPQ consists of 10 statements about treatment satisfaction on a Likert-type scale from 0 (strongly disagree) to 4 (strongly agree). Average scores ≥ 3 indicated acceptable satisfaction. |
Post-intervention (at approximately 8 weeks)
|
|
Pittsburgh Sleep Quality Index
기간: Baseline and post-intervention (approximately 8 weeks)
|
Changes in sleep quality will be assessed pre and post-intervention with the Pittsburgh Sleep Quality Index (PSQI). The PSQI measures sleep quality with a total score ranging from 0-21 with higher scores indicating worse sleep quality. |
Baseline and post-intervention (approximately 8 weeks)
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Functional Outcomes for Cancer Therapy - General
기간: Baseline and post-intervention (approximately 8 weeks)
|
Quality of Life will be assessed via the Functional Outcomes for Cancer Therapy - General (FACT-G). This measure consists of 27 items designed to measure four domains of quality of life in cancer patients: physical, social, emotional, and functional well-being. Coefficients of reliability and validity are uniformly high. The physical, social, and functional domain scores range from 0-28 with higher scores indicating better quality of life. The emotional domain score ranges from 0 - 24 with higher scores indicating better quality of life. The FACT-G total score ranges from 0 - 108, with higher scores indicating better quality of life. |
Baseline and post-intervention (approximately 8 weeks)
|
|
Functional Assessment of Chronic Illness - Fatigue
기간: Baseline and post-intervention (approximately 8 weeks)
|
Fatigue will be assessed with the Functional Assessment of Chronic Illness - Fatigue (FACIT-F) Scale. Higher scores indicate less fatigue (score range=0-52). |
Baseline and post-intervention (approximately 8 weeks)
|
|
Patient Health Questionnaire - 2 (PHQ-2)
기간: Baseline and post-intervention (approximately 8 weeks)
|
The PHQ-2 is a two-item screening questionnaire for depression that asks about the frequency of a depressed mood and loss of interest or pleasure in the last two weeks. Each of the two questions is scored from 0 to 3, based on frequency. The two scores are added together for a total score ranging from 0 to 6. A total score of 3 or higher indicates a positive screen for depression. |
Baseline and post-intervention (approximately 8 weeks)
|
|
Generalized Anxiety Disorder - 7 (GAD-7)
기간: Baseline and post-intervention (approximately 8 weeks)
|
The GAD-7 is used for screening and measuring the severity of generalized anxiety disorder (GAD). The total score indicates the severity of anxiety, from minimal (0-4) to severe (15 and above) |
Baseline and post-intervention (approximately 8 weeks)
|
|
Insomnia Severity Index
기간: Baseline and post-intervention (approximately 8 weeks)
|
Insomnia will be assessed with the Insomnia Severity Index (ISI). A 5-point Likert scale of 7 questions is used to rate each item (e.g., 0 = no problem; 4 = very severe problem), yielding a total score ranging from 0 to 28 with higher scores indicating higher severity of insomnia. |
Baseline and post-intervention (approximately 8 weeks)
|
|
Objective Symptoms of Insomnia- Sleep Duration Via Actigraphy
기간: 2 weeks (worn for 1 week at Baseline and 1 week at post-intervention)
|
Actigraphy will measure the number of minutes of actual sleep. |
2 weeks (worn for 1 week at Baseline and 1 week at post-intervention)
|
|
Objective Symptoms of Insomnia- Wake After Sleep Onset Via Actigraphy
기간: 2 weeks (worn for 1 week at Baseline and 1 week at post-intervention)
|
Actigraphy will measure total minutes of wake time after sleep onset. |
2 weeks (worn for 1 week at Baseline and 1 week at post-intervention)
|
|
Objective Symptoms of Insomnia- Sleep Efficiency via Actigraphy
기간: 2 weeks (worn for 1 week at Baseline and 1 week at post-intervention)
|
Actigraphy will measure the percent of time actually slept compared to intended time sleeping. |
2 weeks (worn for 1 week at Baseline and 1 week at post-intervention)
|
|
Objective Symptoms of Insomnia- Sleep Latency Via Actigraphy
기간: 2 weeks (worn for 1 week at Baseline and 1 week at post-intervention)
|
Actigraphy will measure the minutes it takes for the participant to fall asleep. |
2 weeks (worn for 1 week at Baseline and 1 week at post-intervention)
|
|
Charleson Comorbidity Index
기간: Baseline and post-intervention (approximately 8 weeks)
|
The Charleson Comorbidity Index consists of 19 items, each with an assigned weight from 1 to 6 according to the relative risk of dying within a year. In general, the absence of comorbidity is considered: 0-1 points; low comorbidity: 2 points; and high comorbidity: ≥3 points. |
Baseline and post-intervention (approximately 8 weeks)
|
|
Physical Activity Daily Diaries
기간: Physical activity daily diaries will be completed beginning 1 week pre-intervention, completed throughout the 8-week intervention, and 1-week post-intervention.
|
The physical activity daily diary is designed to gather information about participants' daily physical activity patterns. |
Physical activity daily diaries will be completed beginning 1 week pre-intervention, completed throughout the 8-week intervention, and 1-week post-intervention.
|
|
Sleep Daily Diaries
기간: Sleep daily diaries will be completed beginning 1 week pre-intervention, completed throughout the 8-week intervention, and 1-week post-intervention.
|
The sleep diary is designed to gather information about participants' daily sleep patterns. |
Sleep daily diaries will be completed beginning 1 week pre-intervention, completed throughout the 8-week intervention, and 1-week post-intervention.
|
|
Self-Efficacy for Exercise (SEE) Scale
기간: Baseline and post-intervention (approximately 8 weeks)
|
The Self-Efficacy for Exercise (SEE) scale is a questionnaire designed to measure an individual's confidence in their ability to exercise regularly. Participants rate their confidence on a scale, often from 0 (not at all confident) to 10 (very confident). |
Baseline and post-intervention (approximately 8 weeks)
|
|
Short Acculturation Scale for Hispanics (SASH)
기간: Baseline
|
The Short Acculturation Scale for Hispanics is a 12-item questionnaire developed to measure the degree of acculturation experienced by Hispanics in the United States. Scores range from 1 to 5, where higher scores indicate a greater level of acculturation to mainstream U.S. culture. |
Baseline
|
|
Discrimination in Medical Settings Scale
기간: Baseline and post-intervention (approximately 8 weeks)
|
The Discrimination in Medical Settings (DMS) scale is a 7-item questionnaire that measures patient-reported experiences of mistreatment in healthcare settings. It uses a 5-point Likert scale for each item, asking patients how often they have experienced specific scenarios, such as being treated with less courtesy or feeling a doctor is not listening to them. Higher scores on the scale indicate more frequent experiences of discrimination, and it is used to study disparities in healthcare. |
Baseline and post-intervention (approximately 8 weeks)
|
|
Brief Pain Inventory (BPI)
기간: Baseline and post-intervention (approximately 8 weeks)
|
The Brief Pain Inventory (BPI) is a 9-item self-report tool that measures pain severity and how pain interferes with daily activities on a 0-10 scale, with higher scores indicating greater pain. It shows excellent reliability, with Cronbach's alpha typically between 0.80 and 0.95. |
Baseline and post-intervention (approximately 8 weeks)
|
|
Leisure Time Exercise Questionnaire of Godin and Shephard
기간: Baseline and post-intervention (approximately 8 weeks)
|
The Leisure-Time Exercise Questionnaire (LTEQ) by Godin and Shephard is a brief self-report measure that asks about the frequency of mild, moderate, and strenuous exercise during a typical week. Responses are converted into a weekly leisure activity score by weighting each intensity level. The LTEQ demonstrates good reliability, with Cronbach's alpha values around 0.80 and strong test-retest stability. |
Baseline and post-intervention (approximately 8 weeks)
|
공동 작업자 및 조사자
수사관
수사관
- 수석 연구원: Evelyn Arana, DrPH, Rutgers Cancer Institute
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
연구 시작
기본 완료 (추정된)
기본 완료
연구 완료 (추정된)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
키워드
기타 연구 ID 번호
기타 연구 ID 번호
- Pro2025000098
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .